Sumitomo Mitsui Asset Management Company LTD lessened its holdings in shares of CME Group Inc (NASDAQ:CME) by 7.8% in the first quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 151,181 shares of the financial services provider’s stock after selling 12,723 shares during the quarter. Sumitomo Mitsui Asset Management Company LTD’s holdings in CME Group were worth $24,881,000 at the end of the most recent reporting period.
A number of other large investors have also modified their holdings of CME. Dubuque Bank & Trust Co. boosted its position in CME Group by 83.1% during the first quarter. Dubuque Bank & Trust Co. now owns 152 shares of the financial services provider’s stock worth $25,000 after purchasing an additional 69 shares during the period. Resources Investment Advisors Inc. lifted its holdings in shares of CME Group by 2,800.0% in the fourth quarter. Resources Investment Advisors Inc. now owns 145 shares of the financial services provider’s stock worth $27,000 after buying an additional 140 shares in the last quarter. Ruggie Capital Group purchased a new stake in shares of CME Group in the fourth quarter worth about $28,000. Smith Asset Management Group LP lifted its holdings in shares of CME Group by 200.0% in the fourth quarter. Smith Asset Management Group LP now owns 150 shares of the financial services provider’s stock worth $28,000 after buying an additional 100 shares in the last quarter. Finally, Truvestments Capital LLC purchased a new stake in shares of CME Group in the first quarter worth about $32,000. Hedge funds and other institutional investors own 84.78% of the company’s stock.
In other CME Group news, Director Jeffrey M. Bernacchi sold 10,087 shares of the stock in a transaction that occurred on Tuesday, February 26th. The shares were sold at an average price of $177.94, for a total transaction of $1,794,880.78. Following the transaction, the director now directly owns 42,004 shares in the company, valued at $7,474,191.76. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, Director Ronald A. Pankau sold 200 shares of the stock in a transaction that occurred on Friday, March 1st. The shares were sold at an average price of $182.90, for a total transaction of $36,580.00. Following the transaction, the director now owns 3,600 shares in the company, valued at $658,440. The disclosure for this sale can be found here. Insiders have sold 38,489 shares of company stock worth $6,739,196 over the last quarter. Company insiders own 1.20% of the company’s stock.CME traded down $0.14 on Wednesday, reaching $183.15. The company had a trading volume of 14,863 shares, compared to its average volume of 1,734,197. The company has a market capitalization of $65.23 billion, a P/E ratio of 26.91, a P/E/G ratio of 4.17 and a beta of 0.32. The company has a debt-to-equity ratio of 0.16, a current ratio of 1.04 and a quick ratio of 1.04. CME Group Inc has a 52-week low of $157.21 and a 52-week high of $197.08.
CME Group (NASDAQ:CME) last announced its earnings results on Wednesday, May 1st. The financial services provider reported $1.62 earnings per share for the quarter, beating analysts’ consensus estimates of $1.60 by $0.02. The business had revenue of $1.18 billion for the quarter, compared to the consensus estimate of $1.19 billion. CME Group had a net margin of 42.47% and a return on equity of 9.29%. CME Group’s quarterly revenue was up 6.4% on a year-over-year basis. During the same period last year, the firm posted $1.86 earnings per share. On average, equities analysts anticipate that CME Group Inc will post 6.62 earnings per share for the current year.
The firm also recently declared a quarterly dividend, which will be paid on Tuesday, June 25th. Shareholders of record on Monday, June 10th will be given a dividend of $0.75 per share. This represents a $3.00 dividend on an annualized basis and a yield of 1.64%. The ex-dividend date is Friday, June 7th. CME Group’s payout ratio is currently 43.99%.
CME has been the topic of a number of recent analyst reports. Bank of America set a $180.00 price target on shares of CME Group and gave the stock a “hold” rating in a report on Tuesday, April 9th. ValuEngine raised shares of CME Group from a “hold” rating to a “buy” rating in a report on Wednesday, May 8th. Sanford C. Bernstein reissued an “outperform” rating and issued a $210.00 price target on shares of CME Group in a report on Friday, February 15th. Zacks Investment Research downgraded shares of CME Group from a “hold” rating to a “sell” rating in a research note on Tuesday, April 9th. Finally, BidaskClub downgraded shares of CME Group from a “sell” rating to a “strong sell” rating in a research note on Friday, March 22nd. Two investment analysts have rated the stock with a sell rating, seven have assigned a hold rating and eight have issued a buy rating to the company’s stock. The company presently has a consensus rating of “Hold” and a consensus target price of $189.71.
About CME Group
CME Group Inc, through its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers a range of products across various asset classes, including futures and options based on interest rates, equity indexes, foreign exchange, energy, agricultural commodities, and metals, as well as fixed income products.
Want to see what other hedge funds are holding CME?Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CME Group Inc (NASDAQ:CME).
Receive News & Ratings for CME Group Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for CME Group and related companies with MarketBeat.com’s FREE daily email newsletter.